Show simple item record

dc.contributor.authorAbdelsalam Elshenawy, Rasha
dc.contributor.authorUmaru, Nikkie
dc.contributor.authorAslanpour, Zoe
dc.date.accessioned2024-09-09T16:15:02Z
dc.date.available2024-09-09T16:15:02Z
dc.date.issued2024-08-23
dc.identifier.citationAbdelsalam Elshenawy , R , Umaru , N & Aslanpour , Z 2024 , ' O04 UKHSA Start Smart Then Focus antimicrobial stewardship: effective implementation during the COVID-19 pandemic at an NHS Foundation Trust in the UK ' , JAC-Antimicrobial Resistance , vol. 6 , no. Supplement 2 , pp. ii2-ii3 . https://doi.org/10.1093/jacamr/dlae136.004
dc.identifier.issn2632-1823
dc.identifier.otherORCID: /0000-0002-2567-0540/work/167438486
dc.identifier.otherORCID: /0000-0002-8954-0817/work/167438502
dc.identifier.urihttp://hdl.handle.net/2299/28144
dc.description© 2024 The Author(s). Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY), https://creativecommons.org/licenses/by/4.0/
dc.description.abstractAntimicrobial resistance (AMR) is a critical global health threat, causing 1.2 million deaths annually. While antimicrobial stewardship (AMS) promotes responsible antibiotic use, the COVID-19 pandemic led to a 15% rise in AMR. This study investigated AMS implementation before and during the pandemic through a retrospective analysis of 640 patient records using the UK Health Security Agency’s AMS toolkit at an NHS Foundation Trust. Despite stable antibiotic prescription appropriateness, adherence to guidelines dropped from 64% to 36% during the pandemic. The findings emphasize the importance of adaptable AMS practices, such as ‘De-escalation,’ in managing AMR and ensuring effective healthcare post-pandemic.en
dc.format.extent2
dc.format.extent117125
dc.language.isoeng
dc.relation.ispartofJAC-Antimicrobial Resistance
dc.subjectUKHSA
dc.subjectantimicrobial
dc.subjectantimicrobial agents
dc.subjectAntimicrobial Classification
dc.subjectantimicrobial efficacy
dc.subjectantimicrobial persistence
dc.subjectantimicrobial resistance
dc.subjectAntimicrobial stewardship
dc.subjectantimicrobial stewardship (AMS)
dc.subjectAntimicrobial stewardship competencies
dc.subjectAntimicrobial stewardship programme
dc.subjectAntimicrobial stewardship programs
dc.subjectHealthcare
dc.subjecthealthcare professionals
dc.subjectHealthcare quality improvement
dc.subjectNHS
dc.subjectNHS England
dc.subjectNHS Trust
dc.subjectCOVID
dc.subjectcovid 19
dc.subjectCovid 19 pandemic
dc.subjectCOVID-19 pandemic
dc.subjectCOVID-19
dc.subjectPublic Health
dc.subjectPublic health intervention
dc.subjectPublic education
dc.subjectpublic engagement
dc.subjectGlobal Health
dc.subjectAntimicrobial resistance
dc.subjectAntibiotic awareness week
dc.subjectantibiotic duration
dc.subjectAntibiotic guardian
dc.subjectAntibiotic research
dc.subjectAntibiotic Prescribing
dc.subjectAntibiotic resistance
dc.subjectAntibiotic safety
dc.subjectAntibiotic review
dc.subjectantibiotic utilitsation
dc.subjectmedication
dc.subjectmedication management
dc.subjectMedication optimisation
dc.subjectMedication safety
dc.titleO04 UKHSA Start Smart Then Focus antimicrobial stewardship: effective implementation during the COVID-19 pandemic at an NHS Foundation Trust in the UKen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPublic Health and Patient Safety Unit
dc.contributor.institutionCentre for Future Societies Research
dc.description.statusPeer reviewed
rioxxterms.versionofrecord10.1093/jacamr/dlae136.004
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record